catechin has been researched along with Cardiovascular Diseases in 87 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.15) | 18.2507 |
| 2000's | 27 (31.03) | 29.6817 |
| 2010's | 45 (51.72) | 24.3611 |
| 2020's | 14 (16.09) | 2.80 |
| Authors | Studies |
|---|---|
| Karim, MR; Li, Y; Peng, J; Wang, B | 1 |
| Chen, X; Jia, W; Jiao, J; Liu, X; Wan, X; Wang, A; Wang, Q; Zhang, L; Zhang, Y; Zhu, L; Zhuang, P | 1 |
| Deisling, S; Dicks, L; Ellinger, S; Haddad, Z | 1 |
| Miyoshi, N; Mori, M; Ohishi, T; Sagara, M; Yamori, Y | 1 |
| Brimson, JM; Kumaree, KK; Malar, DS; Prasansuklab, A; Prasanth, MI; Tencomnao, T; Thitilertdecha, P | 1 |
| Alemi, F; Karimian, A; Majidinia, M; Safa, A; Yousefi, B | 1 |
| Sharma, A; Thakur, A; Tuli, HS | 1 |
| Funamoto, M; Hasegawa, K; Katanasaka, Y; Miyazaki, Y; Morimoto, T; Sari, N; Shimizu, K; Shimizu, S; Shimizu, Y; Sunagawa, Y; Wada, H | 1 |
| Athukorala, M; Evans, LW; Ferguson, BS; Martinez-Guryn, K | 1 |
| Iacobazzi, D; Montagnani, M; Potenza, MA; Sgarra, L | 1 |
| Cremonini, E; Iglesias, DE; Kang, J; Lombardo, GE; Mostofinejad, Z; Oteiza, PI; Wang, Z; Zhu, W | 1 |
| Cao, M; Fang, F; Zhang, S | 1 |
| Benlloch, M; Carrera-Juliá, S; Ceron, JJ; Cuerda Ballester, M; de la Rubia Ortí, JE; Drehmer, E; López-Rodríguez, MM; Moreno, ML; Navarro, MÁ; Platero, JL; Tvarijonaviciute, A | 1 |
| Carter, SE; de Graaf, Y; Draijer, R; Holder, SM; Hopkins, ND; Low, DA; Roberts, KA; Thijssen, DHJ | 1 |
| Hinojosa-Nogueira, D; Pastoriza de la Cueva, S; Pérez-Burillo, S; Rufián-Henares, JÁ | 1 |
| Mangels, DR; Mohler, ER | 1 |
| Eng, QY; Ramamurthy, S; Thanikachalam, PV | 1 |
| Farkhondeh, T; Samarghandian, S; Shaterzadeh-Yazdi, H | 1 |
| Adelsbach, M; Berk, L; Ellinger, S; Helfrich, HP; Kirch, N; Liegl, Y; Ludwig, N; Schieber, A; Stehle, P; Stoffel-Wagner, B; Zimmermann, BF | 1 |
| Adriouch, S; Assmann, K; Baudry, J; Fezeu, LK; Hercberg, S; Kesse-Guyot, E; Lampuré, A; Nechba, A; Scalbert, A; Touvier, M | 1 |
| Defernez, M; Hollands, WJ; Kiely, ME; Kroon, PA; Lucey, AJ; Perez Moral, N; Philo, M; Tapp, H; Winterbone, MS | 1 |
| Yang, CS; Zhang, J | 1 |
| Yamagata, K | 1 |
| Amiano, P; Argüelles, MV; Barricarte, A; Boeing, H; Bueno-de-Mesquita, HB; Clavel-Chapelon, F; Crowe, FL; de Magistris, MS; Dilis, V; Engeset, D; Ericson, U; Förster, J; González, CA; Grote, V; Halkjær, J; Huerta, JM; Johansson, I; Khaw, KT; Knaze, V; Landberg, R; Masala, G; Molina-Montes, E; Overvad, K; Peeters, PH; Perquier, F; Riboli, E; Ricceri, F; Romieu, I; Scalbert, A; Sieri, S; Skeie, G; Slimani, N; Tjønneland, A; Touillaud, M; Trichopoulou, A; Tumino, R; Vidalis, P; Weiderpass, E; Wirfält, E; Zamora-Ros, R | 1 |
| Bhardwaj, P; Khanna, D | 1 |
| Chen, G; Wang, H; Yang, ST; Zhang, X | 1 |
| Andriantsitohaina, R; Clere, N; Dayoub, O | 1 |
| Arazi, H; Kheirkhah, J; Samami, N; Taati, B | 1 |
| Howes, MJ; Simmonds, MS | 1 |
| Keske, MA; Kim, JA; Munir, K; Ng, HL; Premilovac, D; Quon, MJ; Rattigan, S; Yang, P | 1 |
| Tagami, M; Yamagata, K; Yamori, Y | 1 |
| Barnett, CF; Ceballos, G; Dugar, S; Moreno-Ulloa, A; Ramirez-Sanchez, I; Schreiner, G; Shiva, S; Su, Y; Taub, PR; Villarreal, F | 1 |
| Scalbert, A; Zamora-Ros, R | 1 |
| Dower, JI; Geleijnse, JM; Gijsbers, L; Hollman, PC; Kromhout, D; Zock, PL | 1 |
| Kerimi, A; Williamson, G | 1 |
| Chakraborti, S; Chakraborti, T; Chowdhury, A; Sarkar, J | 1 |
| Huang, J; Wang, Y; Yang, CS; Zhang, J; Zhang, L | 1 |
| Alfonso, H; Hiramatsu, N; Ishisaka, A; Lee, AH; Takechi, R; Tan, L; Tanaka, A | 1 |
| Moreno-Ulloa, A; Moreno-Ulloa, J | 1 |
| Asanuma, T; Fukui, T; Ishii, T; Mochizuki, K; Nakayama, T; Nakazato, R; Osakabe, N; Saito, A; Shibata, M; Suhara, Y | 1 |
| Dower, JI; Geleijnse, JM; Hollman, PCh; Kromhout, D; Soedamah-Muthu, SS | 1 |
| Ceballos, G; Cicerchi, C; Dugar, S; Gutiérrez-Salmeán, G; Johnson, RJ; Lanaspa, MA; Meaney, E; Ramírez-Sánchez, I; Schreiner, G; Taub, P; Villarreal, F | 1 |
| Goto, S; Isemura, M; Monira, P; Nakamura, Y; Ohishi, T | 1 |
| Peluso, I; Serafini, M | 1 |
| Chen, XQ; Du, Y; Han, Y; Hu, T; Huang, W; Jiang, YW; Yuan, HB; Zhang, YT | 1 |
| Babu, PV; Liu, D | 1 |
| Baumann, G; Jochmann, N; Stangl, V | 1 |
| Frank, J; George, TW; Lodge, JK; Minihane, AM; Rimbach, G; Rodriguez-Mateos, AM; Spencer, JP | 1 |
| Hescheler, J; Jagtap, S; Meganathan, K; Sachinidis, A; Wagh, V; Winkler, J | 1 |
| Isobe, M; Morishita, R; Nagai, R; Suzuki, J | 1 |
| Naito, Y; Yoshikawa, T | 1 |
| Jackson, KG; Minihane, AM; Moore, RJ | 1 |
| Aston, CE; Basu, A; Betts, NM; Blevins, S; Du, M; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M | 1 |
| Jungbauer, A; Liebner, F; Zoechling, A | 1 |
| Ellinger, S; Müller, N; Stehle, P; Ulrich-Merzenich, G | 1 |
| Mak, JC | 1 |
| Gradinaru, D; Ilie, M; Margina, D | 1 |
| Islam, MA | 1 |
| Matsui, T; Suyama, A; Tanaka, M; Zhao, J | 1 |
| Bryant, S; Huntley, AL; Johnson, R | 1 |
| Cassidy, A; Hooper, L; Kay, CD; Kroon, PA; Rimm, EB | 1 |
| Ayabe, M; Ichikawa, H; Ishii, K; Kotani, K; Miyazaki, R; Sakane, N; Shimada, J; Takase, H; Tsuzaki, K; Yonei, Y | 1 |
| Han, CJ; Li, M; Liu, JT; Mao, JJ; Pang, XM | 1 |
| Auger, C; Ito, T; Kim, JH; Kinoshita, Y; Kurita, I; Miyase, T; Schini-Kerth, VB | 1 |
| McCarty, MF | 1 |
| Blazicek, P; Kadrabova, J; Kajaba, I; Krajcovicova-Kudlackova, M; Madaric, A; Mislanova, C; Spustova, V; Valachovicova, M | 1 |
| Frei, B; Higdon, JV | 1 |
| Donovan, JL | 1 |
| Itoh, T; Kangawa, K; Miyatake, K; Miyazawa, T; Nagaya, N; Nakagawa, K; Uematsu, M; Yamamoto, H | 1 |
| Crespy, V; Williamson, G | 1 |
| Goto, C; Moore, MA; Nahomi, I; Tokudome, S; Tokudome, Y | 1 |
| Hernández Figueroa, TT; Rodríguez-Rodríguez, E; Sánchez-Muniz, FJ | 1 |
| Cheng, TO | 1 |
| Fisher, ND; Hollenberg, NK | 1 |
| Appleton, I; Rahman, RM; Sutherland, BA | 1 |
| Zaveri, NT | 1 |
| Artacho, R; Cabrera, C; Giménez, R | 1 |
| Hammerstone, JF; Kwik-Uribe, C; Robbins, RJ; Schmitz, HH | 1 |
| Eric Gershwin, M; Keen, CL; Mao, TK; Schmitz, HH; Selmi, C | 1 |
| Hase, T; Nagao, T; Tokimitsu, I | 1 |
| Basu, A; Lucas, EA | 1 |
| Wolfram, S | 1 |
| Shenouda, SM; Vita, JA | 1 |
| Kamimaki, I; Matsuyama, T; Nagao, T; Tanaka, Y; Tokimitsu, I | 1 |
| Arts, IC; Hollman, PC; Kromhout, D | 1 |
| Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
51 review(s) available for catechin and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of Green Tea (-)-Epigallocatechin-3-Gallate (EGCG) on Cardiac Function - A Review of the Therapeutic Mechanism and Potentials.
Topics: Antioxidants; Calcium; Cardiovascular Diseases; Catechin; Heart Diseases; Humans; Inflammation; Tea | 2022 |
Effect of an (-)-Epicatechin Intake on Cardiometabolic Parameters-A Systematic Review of Randomized Controlled Trials.
Topics: Cacao; Cardiovascular Diseases; Catechin; Chocolate; Humans; Randomized Controlled Trials as Topic; Young Adult | 2022 |
Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels.
Topics: Biomarkers; Cardiovascular Diseases; Catechin; Flavonoids; Genistein; Glycine max; Humans; Neoplasms; Polyphenols; Tea | 2022 |
Tea Plant (
Topics: Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Metabolic Syndrome; Obesity | 2022 |
Targeting miRNAs by polyphenols: Novel therapeutic strategy for aging.
Topics: Aging; Cardiovascular Diseases; Catechin; Gene Expression Regulation; Humans; Longevity; MicroRNAs; Neoplasms; Nervous System Diseases; Polyphenols | 2020 |
The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases.
Topics: Acetylation; Animals; Cardiovascular Diseases; Catechin; Curcumin; Epigenesis, Genetic; Histone Deacetylases; Histones; Humans; Microbiota; Phytochemicals; Protein Processing, Post-Translational; Resveratrol | 2020 |
The Intrinsic Virtues of EGCG, an
Topics: Animals; Antioxidants; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Obesity; Signal Transduction | 2020 |
(-)-Epicatechin and the comorbidities of obesity.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Catechin; Comorbidity; Diabetes Mellitus, Type 2; Dysbiosis; Dyslipidemias; Endoplasmic Reticulum; Endotoxins; Flavonoids; Humans; Inflammation; Insulin Resistance; Lipid Metabolism; Mental Disorders; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress | 2020 |
The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseases.
Topics: Apoptosis; Autophagy; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Neoplasms; Nervous System Diseases; Signal Transduction | 2020 |
Green and white teas as health-promoting foods.
Topics: Antioxidants; Beverages; Cardiovascular Diseases; Catechin; Health Behavior; Humans; Hypertension; Obesity; Phenols; Phytochemicals; Plant Extracts; Tea | 2021 |
Catechins as Potential Mediators of Cardiovascular Health.
Topics: Animals; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Cardiovascular System; Catechin; Diet, Healthy; Hemodynamics; Humans; Micronutrients; Phytochemicals; Protective Factors; Risk Factors | 2017 |
Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.
Topics: Animals; Anti-Inflammatory Agents; Camellia sinensis; Cardiovascular Agents; Cardiovascular Diseases; Catechin; Humans; Metabolic Diseases; Tea | 2018 |
An Overview on Cardiovascular Protective Effects of Catechins.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Catechin; Humans; Hypertension; Oxidative Stress; Protective Agents | 2017 |
Studies on the Prevention of Cancer and Cardiometabolic Diseases by Tea: Issues on Mechanisms, Effective Doses, and Toxicities.
Topics: Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Humans; Neoplasms; Randomized Controlled Trials as Topic; Tea | 2019 |
Polyphenols Regulate Endothelial Functions and Reduce the Risk of Cardiovascular Disease.
Topics: Antioxidants; Cardiovascular Diseases; Catechin; Diet; Endothelium, Vascular; Flavonoids; Humans; Polyphenols; Quercetin; Resveratrol | 2019 |
Green tea catechins: defensive role in cardiovascular disorders.
Topics: Animals; Antioxidants; Camellia sinensis; Cardiovascular Diseases; Catechin; Humans; Oxidative Stress; Plant Extracts | 2013 |
Nutraceuticals and functional foods in the management of hyperlipidemia.
Topics: Cardiovascular Diseases; Catechin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Fiber; Dietary Supplements; Fatty Acids, Omega-3; Functional Food; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Phytosterols; Polyphenols; Tea; Triglycerides | 2014 |
Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction.
Topics: Anthocyanins; Antioxidants; Apoptosis; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Humans; Quercetin; Reactive Oxygen Species | 2013 |
The role of phytochemicals as micronutrients in health and disease.
Topics: Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Dementia; Diabetes Mellitus; Humans; Micronutrients; Neoplasms; Phytochemicals; Plant Extracts; Resveratrol; Stilbenes; Tea; Vitis; Wine | 2014 |
Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.
Topics: Adipose Tissue; Animals; Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Liver; Muscle, Skeletal; Nitric Oxide; Tea | 2015 |
Dietary polyphenols regulate endothelial function and prevent cardiovascular disease.
Topics: Administration, Oral; Animals; Apigenin; Aryldialkylphosphatase; Cardiovascular Diseases; Catechin; Diet; Disease Models, Animal; Endothelial Cells; Endothelin-1; Humans; Lipoproteins, HDL; Nitric Oxide; Nitric Oxide Synthase Type III; Polyphenols; Signal Transduction; U937 Cells | 2015 |
The cardiovascular benefits of dark chocolate.
Topics: Animals; Blood Pressure; Cacao; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Flavonoids; Humans; Theobromine | 2015 |
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Liver; Meta-Analysis as Topic; Metabolic Syndrome; Muscle, Skeletal; Plant Leaves; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Tea; Weight Loss | 2016 |
Anti-inflammatory Action of Green Tea.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Inflammation Mediators; Neoplasms; Neurodegenerative Diseases; Obesity; Reactive Oxygen Species; Tea | 2016 |
Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms.
Topics: Animals; Antioxidants; Biflavonoids; Cardiovascular Diseases; Catechin; Humans; Neoplasms; Oxidation-Reduction; Oxidative Stress; Tea | 2017 |
Preventive Effects of Catechins on Cardiovascular Disease.
Topics: Antioxidants; Blood Pressure; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Humans; Lipid Metabolism; Primary Prevention; Tea | 2016 |
Green tea catechins and cardiovascular health: an update.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Platelets; Cardiovascular Diseases; Cardiovascular System; Catechin; Cell Proliferation; Endothelial Cells; Humans; Inflammation; Lipids; Models, Chemical; Oxidative Stress; Tea | 2008 |
Green tea and cardiovascular disease: from molecular targets towards human health.
Topics: Anti-Inflammatory Agents; Antioxidants; Beverages; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Humans; Plant Extracts; Tea | 2008 |
Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases.
Topics: Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Catechin; Curcumin; Humans; Models, Biological; Molecular Structure; Neoplasms; Oxidative Stress; Quercetin | 2009 |
Tea polyphenols regulate key mediators on inflammatory cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Catechin; Disease Models, Animal; Flavonoids; Humans; Immunohistochemistry; Inflammation; Mice; Models, Biological; NF-kappa B; Nitric Oxide; Phenols; Polyphenols; Rats; Signal Transduction; Tea | 2009 |
Green tea and heart health.
Topics: Animals; Atherosclerosis; Camellia sinensis; Cardiovascular Diseases; Catechin; Cell Adhesion Molecules; Cytokines; Disease Models, Animal; Humans; Lipoproteins, LDL; Oxidation-Reduction; Tea | 2009 |
Green tea (Camellia sinensis) catechins and vascular function.
Topics: Animals; Atherosclerosis; Biological Availability; Blood Vessels; Camellia sinensis; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Catechin; Endothelium, Vascular; Flavonoids; Homeostasis; Humans; Phenols; Phytotherapy; Polyphenols; Signal Transduction; Tea | 2009 |
Consumption of green tea or green tea products: is there an evidence for antioxidant effects from controlled interventional studies?
Topics: Antioxidants; Biomarkers; Cardiovascular Diseases; Catechin; DNA Damage; Female; Flavonols; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Oxidative Stress; Randomized Controlled Trials as Topic; Smoking; Tea | 2011 |
Potential role of green tea catechins in various disease therapies: progress and promise.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Humans; Neoplasms; Neurodegenerative Diseases; Tea | 2012 |
Cardiovascular effects of green tea catechins: progress and promise.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Catechin; Cell Proliferation; Clinical Trials as Topic; Disease Models, Animal; Fibrinolytic Agents; Humans; Inflammation; Models, Cardiovascular; Platelet Aggregation; Signal Transduction; Tea | 2012 |
Green tea and green tea catechin extracts: an overview of the clinical evidence.
Topics: Cardiovascular Diseases; Catechin; Humans; Neoplasms; Randomized Controlled Trials as Topic; Tea; Weight Loss | 2012 |
Relative impact of flavonoid composition, dose and structure on vascular function: a systematic review of randomised controlled trials of flavonoid-rich food products.
Topics: Biomarkers; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Endothelium, Vascular; Flavonoids; Humans; Proanthocyanidins; Randomized Controlled Trials as Topic; Regression Analysis; Structure-Activity Relationship; United States | 2012 |
Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions.
Topics: Animals; Antioxidants; Biological Availability; Biomarkers; Cardiovascular Diseases; Catechin; Chronic Disease; Flavonoids; Free Radical Scavengers; Humans; Neoplasms; Oxidative Stress; Phenols; Polymers; Reactive Oxygen Species; Tea | 2003 |
A review of the health effects of green tea catechins in in vivo animal models.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Catechin; Disease Models, Animal; Enzymes; Hormones; Kidney Diseases; Neoplasms, Experimental; Oxidative Stress; Tea | 2004 |
[The green tea, a good choice for cardiovascular disease prevention?].
Topics: Antioxidants; Biological Availability; Body Water; Camellia sinensis; Cardiovascular Diseases; Catechin; Female; Humans; Lipid Peroxidation; Lipids; Male; Tea | 2004 |
All teas are not created equal: the Chinese green tea and cardiovascular health.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Catechin; Diabetes Mellitus; Endothelium, Vascular; Humans; Metabolic Syndrome; Obesity; Phytotherapy; Plant Extracts; Tea | 2006 |
Flavanols for cardiovascular health: the science behind the sweetness.
Topics: Cacao; Cardiovascular Diseases; Catechin; Flavonoids; Humans; Nitric Oxide Synthase | 2005 |
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.
Topics: Antioxidants; Apoptosis; Brain Ischemia; Camellia sinensis; Cardiovascular Diseases; Catechin; Cerebrovascular Disorders; Flavonoids; Free Radical Scavengers; Ischemia; Lipid Peroxidation; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Phenols; Polyphenols; Tea | 2006 |
Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
Topics: Aging; Animals; Anticarcinogenic Agents; Bacterial Infections; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Flavonoids; Humans; Neurodegenerative Diseases; Obesity; Phenols; Polyphenols; Tea | 2006 |
Beneficial effects of green tea--a review.
Topics: Anticarcinogenic Agents; Antihypertensive Agents; Antimutagenic Agents; Antioxidants; Biological Availability; Camellia sinensis; Cardiovascular Diseases; Catechin; Flavonoids; Health Promotion; Humans; Nutritive Value; Obesity; Phenols; Polyphenols; Tea | 2006 |
Analysis of flavanols in foods: what methods are required to enable meaningful health recommendations?
Topics: Biflavonoids; Cardiovascular Diseases; Catechin; Chromatography, High Pressure Liquid; Flavonoids; Food Analysis; Health Planning Guidelines; Humans; Molybdenum; Phenols; Proanthocyanidins; Reactive Oxygen Species; Tungsten Compounds | 2006 |
The anti-inflammatory properties of cocoa flavanols.
Topics: Anti-Inflammatory Agents; Biflavonoids; Blood Platelets; Cacao; Cardiovascular Diseases; Catechin; Cytokines; Eicosanoids; Flavonoids; Humans; NF-kappa B; Nitric Oxide; Proanthocyanidins | 2006 |
Mechanisms and effects of green tea on cardiovascular health.
Topics: Antioxidants; Beverages; Biological Availability; Cardiovascular Diseases; Catechin; Flavonoids; Humans; Lipid Peroxidation; Phenols; Polyphenols; Risk Factors; Smoking; Tea; Weight Loss | 2007 |
Effects of green tea and EGCG on cardiovascular and metabolic health.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Endothelium, Vascular; Energy Metabolism; Humans; Insulin Resistance; Obesity; Tea | 2007 |
Effects of flavonoid-containing beverages and EGCG on endothelial function.
Topics: Antioxidants; Atherosclerosis; Beverages; Cardiovascular Diseases; Catechin; Endothelium, Vascular; Flavonoids; Humans; Risk Factors | 2007 |
A new function of green tea: prevention of lifestyle-related diseases.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Catechin; Cohort Studies; Cricetinae; Female; Gene Expression Regulation; Humans; Interleukin-6; Japan; Life Style; Lung; Male; Mice; Mice, Transgenic; Neoplasms, Experimental; NF-kappa B; Okadaic Acid; Phytotherapy; Primary Prevention; Prospective Studies; Pulmonary Fibrosis; Rats; Risk; Tea; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2001 |
16 trial(s) available for catechin and Cardiovascular Diseases
| Article | Year |
|---|---|
Metabolomics strategy comprehensively unveils the effect of catechins intervention on the biomarkers of exposure to acrylamide and biomarkers of cardiometabolic risk.
Topics: Acrylamide; Adult; Alanine; Animals; Antioxidants; Aspartic Acid; Biomarkers; Capsules; Cardiovascular Diseases; Catechin; Citric Acid; Glutamic Acid; Glutamine; Glycolipids; Humans; Ketoglutaric Acids; Metabolomics; Phenylalanine; Polyphenols; Rats; Tea | 2022 |
Kosen-cha, a Polymerized Catechin-Rich Green Tea, as a Potential Functional Beverage for the Reduction of Body Weight and Cardiovascular Risk Factors: A Pilot Study in Obese Patients.
Topics: Adult; Body Weight; Cardiovascular Diseases; Catechin; Female; Functional Food; Humans; Male; Middle Aged; Obesity; Pilot Projects; Risk Factors; Tea | 2020 |
Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study.
Topics: 3-Hydroxybutyric Acid; Adult; Analysis of Variance; Anthropometry; Aryldialkylphosphatase; Body Mass Index; C-Reactive Protein; Cardiotonic Agents; Cardiovascular Diseases; Catechin; Dietary Supplements; Female; Heart Disease Risk Factors; Humans; Ketone Bodies; Male; Middle Aged; Multiple Sclerosis; Pilot Projects; Serum Albumin; Treatment Outcome; Waist-Height Ratio | 2020 |
A nutritive dose of pure (-)-epicatechin does not beneficially affect increased cardiometabolic risk factors in overweight-to-obese adults-a randomized, placebo-controlled, double-blind crossover study.
Topics: Adult; Aged; Cardiovascular Diseases; Catechin; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Overweight; Risk Factors; Young Adult | 2018 |
Lack of acute or chronic effects of epicatechin-rich and procyanidin-rich apple extracts on blood pressure and cardiometabolic biomarkers in adults with moderately elevated blood pressure: a randomized, placebo-controlled crossover trial.
Topics: Aged; Biflavonoids; Biomarkers; Blood Pressure; Cardiovascular Diseases; Catechin; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Male; Malus; Middle Aged; Plant Extracts; Proanthocyanidins | 2018 |
The effect of three weeks green tea extract consumption on blood pressure, heart rate responses to a single bout resistance exercise in hypertensive women.
Topics: Adult; Analysis of Variance; Antioxidants; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypertension; Middle Aged; Plant Extracts; Resistance Training; Risk Factors; Tea; Treatment Outcome | 2014 |
Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (-)-epicatechin in healthy volunteers.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Platelets; Cardiovascular Diseases; Catechin; Citrate (si)-Synthase; Dietary Supplements; Electron Transport Chain Complex Proteins; Female; Follistatin; Humans; Intestinal Absorption; Kinetics; Male; Middle Aged; Nitric Oxide; Toxicity Tests, Subchronic; Young Adult | 2015 |
Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cacao; Cardiovascular Diseases; Catechin; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Female; Healthy Volunteers; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Nitric Oxide; Quercetin; Tea; Triglycerides; Vascular Stiffness | 2015 |
The impact of theaflavins on systemic-and microcirculation alterations: The murine and randomized feasibility trials.
Topics: Adult; Animals; Biflavonoids; Blood Circulation; Camellia sinensis; Cardiovascular Diseases; Catechin; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Feasibility Studies; Female; Glycosides; Humans; Male; Mice; Microcirculation; Middle Aged; Pilot Projects; Plant Leaves; Rats, Wistar; Reproducibility of Results; Young Adult | 2016 |
A randomized, placebo-controlled, double-blind study on the effects of (-)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects.
Topics: Adolescent; Adult; Cardiovascular Diseases; Catechin; Cells, Cultured; Cholesterol, HDL; Double-Blind Method; Female; Humans; Hypertriglyceridemia; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Triglycerides; Young Adult | 2016 |
Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men.
Topics: Adolescent; Adult; Biomarkers; Camellia sinensis; Cardiovascular Diseases; Catechin; Chromans; Creatinine; Double-Blind Method; Humans; Liver; Male; Middle Aged; Plant Extracts; Propionates | 2009 |
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.
Topics: Adult; Antioxidants; Biomarkers; C-Reactive Protein; Camellia sinensis; Cardiovascular Diseases; Catechin; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Plant Extracts; Single-Blind Method; Tea; Vascular Cell Adhesion Molecule-1 | 2011 |
Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Catechin; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Tea; Time Factors; Treatment Outcome; Walking | 2013 |
Green tea reverses endothelial dysfunction in healthy smokers.
Topics: Adult; Analysis of Variance; Antioxidants; Beverages; Camellia sinensis; Cardiovascular Diseases; Catechin; Cross-Over Studies; Drinking; Endothelium, Vascular; Humans; Male; Phytotherapy; Plant Preparations; Smoking | 2004 |
A green tea extract high in catechins reduces body fat and cardiovascular risks in humans.
Topics: Adipose Tissue; Adult; Blood Pressure; Body Weight; Cardiovascular Diseases; Catechin; Cholesterol; Female; Humans; Male; Middle Aged; Obesity; Plant Extracts; Risk Factors; Tea | 2007 |
Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children.
Topics: Adipose Tissue; Adolescent; Beverages; Blood Pressure; Cardiovascular Diseases; Catechin; Child; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Humans; Male; Obesity; Outcome Assessment, Health Care; Risk Factors | 2008 |
20 other study(ies) available for catechin and Cardiovascular Diseases
| Article | Year |
|---|---|
Natural Moieties as Anti-Inflammatory Agents-Recent Patents.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Biological Products; Cardiovascular Diseases; Catechin; Coumaric Acids; Humans; Inflammation; Neoplasms; Neurodegenerative Diseases; Patents as Topic; Plants; Polyphenols; Quercetin | 2019 |
Impact of green tea on the deleterious cardiometabolic effects of 7-days unhealthy lifestyle in young healthy males.
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Catechin; Double-Blind Method; Humans; Insulin; Life Style; Male; Middle Aged; Postprandial Period; Tea; Young Adult | 2021 |
Prospective Association between Total and Specific Dietary Polyphenol Intakes and Cardiovascular Disease Risk in the Nutrinet-Santé French Cohort.
Topics: Aged; Anthocyanins; Cardiovascular Diseases; Catechin; Diet; Diet Records; Eating; Female; Flavonols; Humans; Incidence; Male; Middle Aged; Polyphenols; Proportional Hazards Models; Prospective Studies; Risk Factors | 2018 |
Impact of thearubigins on the estimation of total dietary flavonoids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
Topics: Adult; Aged; Cardiovascular Diseases; Catechin; Diet; Europe; Flavonoids; Humans; Life Style; Male; Mental Recall; Middle Aged; Neoplasms; Nutritional Status; Polyphenols; Prospective Studies; Tea; White People | 2013 |
Bridging evidence from observational and intervention studies to identify flavonoids most protective for human health.
Topics: Beverages; Cardiovascular Diseases; Cardiovascular System; Catechin; Endothelium, Vascular; Female; Flavonoids; Hesperidin; Humans; Male; Mortality; Neoplasms; Phenols; Quercetin | 2015 |
Role of Spm-Cer-S1P signalling pathway in MMP-2 mediated U46619-induced proliferation of pulmonary artery smooth muscle cells: protective role of epigallocatechin-3-gallate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiovascular Agents; Cardiovascular Diseases; Catechin; Cattle; Cell Culture Techniques; Cell Proliferation; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocytes, Smooth Muscle; Pulmonary Artery; Vasoconstrictor Agents | 2015 |
Elevated plasma and urinary concentrations of green tea catechins associated with improved plasma lipid profile in healthy Japanese women.
Topics: Adipose Tissue; Adult; Aged; Asian People; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Catechin; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Japan; Middle Aged; Plant Extracts; Tea; Triglycerides | 2016 |
Mortality reduction among persons with type 2 diabetes: (-)-Epicatechin as add-on therapy to metformin?
Topics: Animals; Cardiovascular Diseases; Catechin; Chocolate; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Metformin; Myocardial Infarction; Rats; Reperfusion Injury | 2016 |
Dietary epicatechin intake and 25-y risk of cardiovascular mortality: the Zutphen Elderly Study.
Topics: Aged; Aged, 80 and over; Cacao; Camellia sinensis; Cardiovascular Diseases; Catechin; Coronary Disease; Diet; Energy Intake; Flavonoids; Humans; Male; Malus; Phytotherapy; Plant Extracts; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke | 2016 |
Would you recommend drinking green tea for its supposed health benefits?
Topics: Asia; Cardiovascular Diseases; Cardiovascular System; Catechin; Flavonoids; Humans; Phenols; Polyphenols | 2008 |
Red wine: a source of potent ligands for peroxisome proliferator-activated receptor γ.
Topics: Binding, Competitive; Cardiovascular Diseases; Catechin; Coumaric Acids; Diabetes Mellitus, Type 2; Ellagic Acid; Flavonoids; Gas Chromatography-Mass Spectrometry; Humans; Hypoglycemic Agents; Ligands; Models, Chemical; Phenols; Plant Extracts; Polyphenols; PPAR gamma; Rosiglitazone; Spectroscopy, Fourier Transform Infrared; Thiazolidinediones; Wine | 2011 |
Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells.
Topics: Adult; Aged; Anisotropy; Biomarkers; Cardiovascular Diseases; Catechin; Cell Membrane; Cell Polarity; Diabetes Mellitus, Type 2; Diet, Vegetarian; Female; Humans; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Leukocytes, Mononuclear; Male; Membrane Fluidity; Membrane Potentials; Middle Aged; Quercetin; Resistin | 2012 |
Epigallocatechin gallate promotes the vasorelaxation power of the antiatherosclerotic dipeptide Trp-His in contracted rat aorta.
Topics: Animals; Aorta; Cardiovascular Diseases; Catechin; Dipeptides; Drug Synergism; Humans; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 2012 |
Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages.
Topics: Angiotensin II; Anti-Inflammatory Agents; C-Reactive Protein; Cardiovascular Diseases; Catechin; Cell Line, Tumor; Humans; Inflammation; Interleukin-6; Macrophages; Reactive Oxygen Species; RNA, Messenger; Tea; U937 Cells | 2012 |
Hydroxylation of (-)-epigallocatechin-3-O-gallate at 3'', but not 4'', is essential for the PI3-kinase/Akt-dependent phosphorylation of endothelial NO synthase in endothelial cells and relaxation of coronary artery rings.
Topics: Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Coronary Vessels; Endothelial Cells; Humans; Hydroxylation; In Vitro Techniques; Molecular Structure; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-akt; Swine; Vasodilation | 2013 |
Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Catechin; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Models, Biological; Nitrates; Nitric Oxide; Polyphenols; Quercetin | 2013 |
The effect of bioactive complex of quercetin, selenium, catechins and curcumin on cardiovascular risk markers in healthy population after a two month consumption.
Topics: Adult; Antioxidants; Cardiovascular Diseases; Catechin; Curcumin; Dietary Supplements; Functional Food; Humans; Male; Middle Aged; Quercetin; Risk Factors; Selenium | 2013 |
Flavonoids and the risk of cardiovascular disease in women.
Topics: Cardiovascular Diseases; Catechin; Female; Flavonoids; Food Analysis; Humans; Risk Factors; Terminology as Topic | 2004 |
Black tea and cardiovascular disease.
Topics: Cardiovascular Diseases; Catechin; Confounding Factors, Epidemiologic; Flavonoids; Humans; Tea | 2005 |
Chocolate as a source of tea flavonoids.
Topics: Cacao; Cardiovascular Diseases; Catechin; Flavonoids; Humans; Neoplasms; Netherlands; Tea | 1999 |